The impact of hospice care on survival and cost saving among patients with liver cancer: a national longitudinal population-based study in Taiwan

@article{Chiang2014TheIO,
  title={The impact of hospice care on survival and cost saving among patients with liver cancer: a national longitudinal population-based study in Taiwan},
  author={Jui-Kun Chiang and Yee-Hsin Kao},
  journal={Supportive Care in Cancer},
  year={2014},
  volume={23},
  pages={1049-1055}
}
PurposeThe aim of this study was to compare health-care expenditures and survival of these terminally ill patients receiving or not receiving hospice care in their last month of life.MethodsUsing Taiwan’s National Health Insurance Claims Database, we analyzed hospitalizations, OPD visits, associated costs, and survival. Logistic regression was used to identify predictors of high cost.ResultsWe identified 3850 liver cancer patients who died during the 1997–2011 study period, 644 (16.6 %) of whom… Expand
Effect of hospice care on health-care costs for Taiwanese patients with cancer during their last month of life in 2004–2011: A trend analysis
TLDR
Health-care costs in the last month of life are increasing over time in Taiwan, and patients receiving hospice care can be as much as 16.3% lower than patients not receiving Hospice care. Expand
Differences in medical costs for end-of-life patients receiving traditional care and those receiving hospice care: A retrospective study
TLDR
Hospice care can effectively save a large amount of end-of-life medical costs, and more medical costs are saved when patients are referred to hospice care earlier. Expand
Costs of care at the end of life among elderly patients with chronic kidney disease: patterns and predictors in a nationwide cohort study
TLDR
Overall EOL costs and rates of intensive service use among older patients with CKD were high, with significant variability across various patient and provider characteristics. Expand
How we use hospice: Hospice enrollment patterns and costs in elderly ovarian cancer patients.
TLDR
Recently, more patients remain enrolled in hospice, but black patients have a higher risk of unenrollment, and Hospice enrollment was associated with lower costs as long as a patient did not unenroll from hospice. Expand
Hospice care for end stage liver disease in the United States
TLDR
This review examines the evidence support for hospice for ESLD, compares this evidence to that supporting hospice more broadly, and identifies potential criteria that may be useful in determining hospice appropriateness. Expand
Evaluation of home care services at a training and research hospital in Izmir
170 ABSTRACT Objectives: To define the demographic characteristics, health and dependence status of patients receiving home care services (HCSs) and the services needed and received by the patients.Expand
Cancer survival in Qidong between 1972 and 2011: A population-based analysis.
TLDR
Improved survival rates in the most recent two 5-year calendar periods were identified for stomach, lung, colon and rectum, oesophagus, female breast and bladder cancer, as well as leukaemia and NHL. Expand
Economic Implications of Hepatocellular Carcinoma Surveillance and Treatment: A Guide for Clinicians
TLDR
A focused review of studies investigating the economic burden and cost effectiveness of HCC surveillance treatment modalities published between January 2000 and January 2019 found that Liver transplantation is a cost-effective strategy for early-stage HCC treatment in selected patients. Expand
Factors correlating with shorter survival after treatment: aiding oncologists to choose who (not) to receive palliative systemic therapy
TLDR
Oncologists should exercise extra caution when encountering elderly patients with active liver metastasis, especially with regard to the issue of starting palliative systemic therapy, and identify factors correlating with a shorter (≤6 weeks) non-malignancy related survival in metastatic cancer patients receiving palliatives systemic therapy. Expand
Current Knowledge, Barriers to Implementation, and Future Directions in Palliative Care for End‐Stage Liver Disease
  • Zachary P. Fricker, M. Serper
  • Medicine
  • Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
  • 2019
TLDR
The benefits of PC in ESLD, the variability of its delivery, and key stakeholders’ perceptions about its use are discussed, and barriers to more widespread PC adoption are identified. Expand
...
1
2
...

References

SHOWING 1-10 OF 26 REFERENCES
Association of healthcare expenditures with aggressive versus palliative care for cancer patients at the end of life: a cross-sectional study using claims data in Japan.
TLDR
Indicators of both aggressive and palliative EOL care were associated with higher healthcare expenditures, which may support the coherent development of measures to optimize aggressive care and reduce the financial burdens of terminal cancer care. Expand
Hospice shared-care saved medical expenditure and reduced the likelihood of intensive medical utilization among advanced cancer patients in Taiwan—a nationwide survey
TLDR
HSC is associated with significant medical expenditure savings and reduced likelihood of intensive medical utilization by advanced cancer patients and all types of HPC are associated withmedical expenditure savings. Expand
Trends in quality of end-of-life care for Taiwanese cancer patients who died in 2000-2006.
TLDR
The quality of end-of-life care for Taiwanese cancer decedents was substantially inferior to that previously reported and to that recommended as benchmarks for not providing overly aggressive care near the end of life. Expand
Resource consumption and costs of palliative care services in Spain: a multicenter prospective study.
TLDR
Compared to the previous resource consumption and expenditure study in 1992, the current PCS policy implies a cost saving of 61%, with greater efficiency and no compromise of patient care. Expand
Hospice care and survival among elderly patients with lung cancer.
TLDR
Hospice enrollment did not compromise length of survival following advanced lung cancer diagnosis and patients experiencing short-term hospice admissions within 3 days of death received less aggressive end-of-life care compared to nonhospice patients. Expand
Comparing hospice and nonhospice patient survival among patients who die within a three-year window.
TLDR
Across groups studied, hospice enrollment is not significantly associated with shorter survival, but for certain terminally ill patients, hospices is associated with longer survival times, and the findings apply to cases where a clinician is very sure the patient will die within three years. Expand
Impact of hospice disenrollment on health care use and medicare expenditures for patients with cancer.
  • M. Carlson, J. Herrin, +5 authors E. Bradley
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2010
TLDR
Hospitalization, emergency department, and intensive care unit admission and hospital death for hospice disenrollees and those who remained with hospice until death and per-day Medicare expenditures across the two groups are compared. Expand
Trends in the aggressiveness of cancer care near the end of life.
TLDR
The treatment of cancer patients near death is becoming increasingly aggressive over time and greater local availability of hospices was associated with less aggressive treatment near death on multivariate analysis. Expand
Multivariate Analyses to Assess the Effects of Surgeon and Hospital Volume on Cancer Survival Rates: A Nationwide Population-Based Study in Taiwan
TLDR
After adjusting for differences in the case mix, cancer patients treated by low-volume surgeons in low- volume hospitals had poorer 5-year survival rates, and patients’ demographic variables, co-morbidities, and treatment modality may need to be adjusted for. Expand
Cost savings at the end of life. What do the data show?
TLDR
The existing data suggest that hospice and advance directives can save between 25% and 40% of health care costs during the last month of life, with savings decreasing to 10% to 17% over the last 6 months of life and decreasing further to 0% to 10%, less than most people anticipate. Expand
...
1
2
3
...